SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-033931
Filing Date
2024-11-07
Accepted
2024-11-07 16:16:28
Documents
91
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q opk20240930_10q.htm   iXBRL 10-Q 2593511
2 EXHIBIT 31.1 ex_716426.htm EX-31.1 12387
3 EXHIBIT 31.2 ex_716427.htm EX-31.2 12309
4 EXHIBIT 32.1 ex_716428.htm EX-32.1 3894
5 EXHIBIT 32.2 ex_716429.htm EX-32.2 3799
  Complete submission text file 0001437749-24-033931.txt   12974498

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA opk-20240930.xsd EX-101.SCH 93707
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE opk-20240930_cal.xml EX-101.CAL 79590
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE opk-20240930_def.xml EX-101.DEF 741489
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE opk-20240930_lab.xml EX-101.LAB 608310
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE opk-20240930_pre.xml EX-101.PRE 783548
94 EXTRACTED XBRL INSTANCE DOCUMENT opk20240930_10q_htm.xml XML 2460246
Mailing Address 4400 BISCAYNE BLVD. MIAMI FL 33137
Business Address 4400 BISCAYNE BLVD. MIAMI FL 33137 305-575-4181
OPKO HEALTH, INC. (Filer) CIK: 0000944809 (see all company filings)

IRS No.: 752402409 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33528 | Film No.: 241436012
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)